1. Decision of the Council of the Eurasian Economic Commission dated November 3, 2016 N 87 “On Approval of the Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union” [cited by Jan 08, 2021]. Available: https://www.alta.ru/tamdoc/16sr0087/ (In Russ.)
2. Martsevich SY, Navasardjan AR, Komkova NA. Off-Label Prescribing. Possible Causes, Types and Consequences. Legal Regulation in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2017;13(5):667-74 (In Russ). DOI:10.20996/1819-6446-2017-13-5-667-674.
3. Federal Law “On the fundamentals of protecting the health of citizens in the Russian Federation” of November 21, 2011 N 323-FZ (last version) [cited by Jan 08, 2021]. Available: http://www.consultant.ru/document/cons_doc_LAW_121895/ (In Russ.)
4. Order of the Ministry of Health of Russia dated March 28, 2019 No. 167n [cited by Jan 08, 2021]. Available: https://rulaws.ru/acts/Prikaz-Minzdrava-Rossii-ot-28.03.2019-N-167n/ (In Russ.) [Приказ Минздрава России от 28.03.2019 №167н [цитировано 08.01.2021]. Доступно: https://rulaws.ru/acts/Prikaz-Minzdrava-Rossii-ot-28.03.2019-N-167n/].
5. Order of the Ministry of Health of Russia dated 02.28.2019 N 101n "On approval of the criteria for the formation of a list of diseases, conditions (groups of diseases, conditions) for which clinical guidelines are developed" (Registered with the Ministry of Justice of Russia 05.28.2019) [cited by Jan 08, 2021]. Available: http://www.consultant.ru/document/cons_doc_LAW_325476/ (In Russ.)